Evidence reviews to support NHS England commissioning policies | COVID-19 rapid guideline: managing COVID-19 | Guidance | NICE

Download (PDF)

Evidence reviews to support NHS England commissioning policies

These evidence reviews were developed to support the following NHS England commissioning policies. NICE has conducted a more recent review of the evidence for its rapid guideline.

NHSE commissioning policies

Interim Clinical Commissioning Policy: Remdesivir for patients hospitalised with COVID-19 (adults and children 12 years and older)
Interim Clinical Commissioning Policy: Tocilizumab for hospitalised patients with COVID-19 pneumonia (adults)
Interim Clinical Commissioning Policy: Sarilumab for critically ill patients with COVID-19 pneumonia (adults).

Download the associated evidence reviews:

This page was last updated: 23 March 2021